HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abraham Anderson Selected Research

Antigens

1/2021Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abraham Anderson Research Topics

Disease

7Neoplasms (Cancer)
01/2021 - 01/2010
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 04/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2021
2Melanoma (Melanoma, Malignant)
01/2021 - 01/2016
2Bites and Stings (Sting)
01/2021 - 04/2020
2Fatigue
09/2011 - 05/2010
2Nausea
09/2011 - 05/2010
1Philadelphia Chromosome
01/2021
1Residual Neoplasm
01/2021
1Lung Neoplasms (Lung Cancer)
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2017
1Neoplasm Metastasis (Metastasis)
08/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
08/2014
1Neutropenia
08/2014
1Venous Thromboembolism
08/2014
1Adenocarcinoma
08/2014
1Thrombocytopenia (Thrombopenia)
08/2014
1Renal Cell Carcinoma (Grawitz Tumor)
09/2011
1Gliosarcoma
04/2011
1Glioblastoma (Glioblastoma Multiforme)
04/2011
1Cholecystitis
05/2010
1Constipation
05/2010
1Edema (Dropsy)
05/2010

Drug/Important Bio-Agent (IBA)

5Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2014 - 01/2010
5rilotumumabIBA
08/2014 - 01/2010
4Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2010
4Monoclonal AntibodiesIBA
09/2011 - 01/2010
3blinatumomabIBA
01/2021 - 04/2020
2talimogene laherparepvecIBA
01/2021 - 01/2016
1sotorasibIBA
01/2021
1AntigensIBA
01/2021
1N- (4- ((3- (2- amino- 4- pyrimidinyl)- 2- pyridinyl)oxy)phenyl)- 4- (4- methyl- 2- thienyl)- 1- phthalazinamineIBA
07/2017
1Aurora KinasesIBA
07/2017
1CTLA-4 AntigenIBA
01/2016
1IpilimumabIBA
01/2016
1Cisplatin (Platino)FDA LinkGeneric
08/2014
1Epirubicin (Ellence)FDA LinkGeneric
08/2014
1Capecitabine (Xeloda)FDA Link
08/2014
1Dihydrotachysterol (AT 10)IBA
09/2011
1motesanib diphosphateIBA
05/2010
1Bevacizumab (Avastin)FDA Link
05/2010

Therapy/Procedure

5Therapeutics
01/2022 - 04/2011
1Drug Therapy (Chemotherapy)
01/2021